SCHEMBL21895733

SCHEMBL21895733

C=CC[C@@H](CCCC)COc1nc(CC)c(CCC(C=C)Cc2cc(OC)cc3ccccc23)c(N(CCC)C[C@@H](C)CC#N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21895630 0.86 — —
SCHEMBL21912088 0.83 — —
SCHEMBL25020009 0.82 — —
SCHEMBL21895589 0.74 — —
SCHEMBL21895564 0.72 — —
SCHEMBL21895619 0.72 — —
SCHEMBL21846275 0.71 — —
SCHEMBL21912124 0.71 — —
SCHEMBL21895625 0.70 — —
SCHEMBL21846435 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055756-A1 COMBINATION THERAPIES Mirati Therapeutics, Inc. (US) 2020-03-19 — — WO disclosed
Send feedback